BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Anivive Announces Positive Study Results for Antifungal Vaccine to Prevent Canine Valley Fever

  Anivive, a pet health technology company transforming the therapeutic discovery and development process, announced positive results from a study on its groundbreaking fungal vaccine for Valley Fever in dogs.

  June 17, 2021

   · 

  3 min read
• Drug Development

  Jacobio Announces First Two Patients Dosed in SHP2 Combination Study, Triggering US$20 Million Milestone Payment

  Jacobio Pharmaceuticals has announced that the first two patients have been dosed in the Phase 1/2a clinical trial of SHP2 inhibitor JAB-3312 in combination with PD-1 antibody Pembrolizumab and MEK inhibitor Binimetinib respectively, thereby triggering the US$20 million milestone payment from AbbVie.

  June 17, 2021

   · 

  3 min read
• Deals

  Codex DNA Announces Pricing of Initial Public Offering

  Codex DNA, Inc., creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, announced the pricing of its initial public offering of 6,666,665 shares of its common stock at a public offering price of $16.00 per share.

  June 17, 2021

   · 

  2 min read